Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.77 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.77 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.77 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.77 |
| ▸ | F2 | P00734 | 3/20 | 0.68 |
| ▸ | PPARG | P37231 | 1/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | F10 | P00742 | 2/20 | 0.57 |
| ▸ | PLG | P00747 | 2/20 | 0.57 |
| ▸ | PLAU | P00749 | 2/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL979496 | 1.00 | CASP3 (0.77) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL23717137 | 0.87 | F2 (0.64) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL11688369 | 0.87 | F2 (0.64) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL29941485 | 0.87 | CASP3 (1.00) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL3704691 | 0.87 | CASP3 (1.00) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL11565448 | 0.86 | CHEK2 (0.67) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL4334503 | 0.86 | CASP3 (0.57) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL164956 | 0.86 | CASP3 (0.57) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL693160 | 0.86 | F2 (0.58) | CASP3SENP8SENP7SENP6F2 | |
| SCHEMBL11563588 | 0.86 | CASP3 (0.57) | CASP3SENP8SENP7SENP6F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250082646-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | MITOIMMUNE THERAPEUTICS INC. (KR) | 2025-03-13 | — | — | US | disclosed |
| EP-4470541-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | MitoImmune Therapeutics Inc. (KR) | 2024-12-04 | — | — | EP | disclosed |
| US-11390610-B2 | Piperazine derivatives as MAGL inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2022-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250082646-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | CYP19A1, NR5A1, CYP11A1 | CASP3 2183/4885SENP8 1107/4885SENP7 494/4885 |
| US-11390610-B2 | Piperazine derivatives as MAGL inhibitors | MAGI3, PYM1, MAG | CASP3 4280/4885SENP8 4307/4885SENP7 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.